Cargando…

A Genome-Wide Investigation of Effects of Aberrant DNA Methylation on the Usage of Alternative Promoters in Hepatocellular Carcinoma

BACKGROUND: The alternative usage of promoters provides a way to regulate gene expression, has a significant influence on the transcriptome, and contributes to the cellular transformation of cancer. However, the function of alternative promoters (APs) in hepatocellular carcinoma (HCC) has not been s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yuting, Liu, Xiaozhao, Jiang, Bijun, Wei, Siting, Xiang, Bangde, Liao, Ruichu, Wang, Qiuyan, He, Ximiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803206/ https://www.ncbi.nlm.nih.gov/pubmed/35111672 http://dx.doi.org/10.3389/fonc.2021.780266

Ejemplares similares

Corrigendum: A genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma
por: Dong, Yuting, et al.
Publicado: (2023)

Prognostic Value of Aspartate Transaminase/Alanine Transaminase Ratio in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Hepatectomy
por: Mo, Qiuyan, et al.
Publicado: (2022)

Identification of Aberrantly Methylated Differentially CpG Sites in Hepatocellular Carcinoma and Their Association With Patient Survival
por: Guan, Renguo, et al.
Publicado: (2020)

Integrative Analysis of Epigenome and Transcriptome Data Reveals Aberrantly Methylated Promoters and Enhancers in Hepatocellular Carcinoma
por: Huang, Peng, et al.
Publicado: (2021)

Multimodal analysis of genome-wide methylation, copy number aberrations, and end motif signatures enhances detection of early-stage breast cancer
por: Pham, Thi Mong Quynh, et al.
Publicado: (2023)

Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
por: Muylaert, Catharina, et al.
Publicado: (2022)

Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications
por: Lin, Lehang, et al.
Publicado: (2020)

Aberrant DNA methylation defines isoform usage in cancer, with functional implications
por: Chen, Yun-Ching, et al.
Publicado: (2019)

RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
por: Sartorius, Kurt, et al.
Publicado: (2022)

Evidence for a Functional Link between Chromosomal Breakpoints and Aberrant DNA Methylation in Cancer
por: Bilke, Sven, et al.
Publicado: (2014)

New Studies of the Aberrant Alterations in Fibrillin-1 Methylation During Colorectal Cancer Development
por: Lv, Ling, et al.
Publicado: (2022)

Integrated Genomic and Transcriptomic Analysis reveals key genes for predicting dual-phenotype Hepatocellular Carcinoma Prognosis
por: Wang, Yaobang, et al.
Publicado: (2021)

Alternative and aberrant splicing of human endogenous retroviruses in cancer. What about head and neck? —A mini review
por: Agoni, Lorenzo
Publicado: (2022)

Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2021)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer
por: Zong, Zhen, et al.
Publicado: (2018)

Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer
por: Yu, Min, et al.
Publicado: (2019)

Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma
por: Krivtsova, Olga, et al.
Publicado: (2018)

Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
por: Song, Min-Ae, et al.
Publicado: (2013)

An aberrant DNA methylation signature for predicting hepatocellular carcinoma
por: Zhang, Renhua, et al.
Publicado: (2020)

Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma
por: Wang, Yongkang, et al.
Publicado: (2021)

Potential methylation-regulated genes and pathways in hepatocellular neoplasm, not otherwise specified
por: Zhou, Shengmei, et al.
Publicado: (2022)

KIAA1429 regulates alternative splicing events of cancer-related genes in hepatocellular carcinoma
por: Liu, Zhao-chen, et al.
Publicado: (2022)

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma
por: Fan, Zhongru, et al.
Publicado: (2021)

Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review)
por: DONG, YOUHONG, et al.
Publicado: (2014)

Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilobar lesion combining with systemic therapies and sequential hepatectomy
por: Wei, Yong-Guang, et al.
Publicado: (2023)

Case Report: Radiotherapy Plus Immunotherapy and Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma With a Right Atrium and Inferior Vena Cava Tumor Thrombus
por: Qian, Yuting, et al.
Publicado: (2022)

Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma
por: Qin, Shijie, et al.
Publicado: (2021)

RNF135 Promoter Methylation Is Associated With Immune Infiltration and Prognosis in Hepatocellular Carcinoma
por: Wang, Xiao, et al.
Publicado: (2022)

Radiomics nomogram based on multi-parametric magnetic resonance imaging for predicting early recurrence in small hepatocellular carcinoma after radiofrequency ablation
por: Zhang, Xiaojuan, et al.
Publicado: (2022)

Genome-Wide Identification and Analysis of the Methylation of lncRNAs and Prognostic Implications in the Glioma
por: He, Yijie, et al.
Publicado: (2021)

Association between telomere length and hepatocellular carcinoma risk: A Mendelian randomization study
por: Yang, Chenglei, et al.
Publicado: (2023)

Aberrations of Genomic Imprinting in Glioblastoma Formation
por: Lozano-Ureña, Anna, et al.
Publicado: (2021)

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma
por: Qu, Nanfang, et al.
Publicado: (2021)

Sox15 Methylation Inhibits Cell Proliferation Through Wnt Signaling in Hepatocellular Carcinoma
por: Wei, Bajin, et al.
Publicado: (2022)

DNA methylation regulators-related molecular patterns and tumor immune landscape in hepatocellular carcinoma
por: Song, Dingli, et al.
Publicado: (2022)

CircASPH Promotes Hepatocellular Carcinoma Progression Through Methylation and Expression of HAO2
por: Zhuo, Han, et al.
Publicado: (2022)

Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma
por: Gao, Wenzhi, et al.
Publicado: (2023)

Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma
por: Cai, Changzhou, et al.
Publicado: (2019)

Clinical significance of aberrant DEUP1 promoter methylation in hepatocellular carcinoma
por: Yu, Qiwen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_894n5js1lejgjud59j6dm27t36